by Greg Kuehn | Dec 10, 2013 | Research News
POTOMAC FALLS, VA, December 10, 2013 Metabiomics is pioneering the development of molecular diagnostic tests for colorectal cancer, inflammatory bowel disease, and other gastrointestinal cancers and autoimmune diseases built on an exclusive worldwide license from...
by Greg Kuehn | Sep 23, 2013 | Press Releases
PRESS RELEASE CHEVY CHASE, MD. September 23, 2013 — Metabiomics is pleased to announce the addition of four new members to the management team and advisory board. Dr. Louis Korman has joined the Metabiomics management team as Chief Medical Officer. Dr. Robert...
by Greg Kuehn | Aug 1, 2013 | Press Releases
Metabiomics is pleased to announce the addition of a new key member to our management team. Dr. David Hanzel has joined Metabiomics as our President and Chief Operating Officer. Dr. Hanzel has an ideal background in the science and business of DNA sequencing, health...
by Greg Kuehn | Jun 21, 2013 | Press Releases
POTOMAC FALLS, VA, June 21, 2013 Metabiomics, an early stage microbiome diagnostics company, will be presenting an investment opportunity next week at OneMedForumNY in New York. The 4th annual OneMedForumNY investor conference will be held on June 26-27 at the...
